Acadia Healthcare Company, Inc. Stockholders Equity

• Acadia Healthcare Company, Inc. showed a decrease of -36.6% in Stockholders Equity from 2024 to 2025.
• This data is from Acadia Healthcare Company, Inc.'s annual report (Form 10-K), filed with the SEC on February 27, 2026.
• XBRL data for this metric is available from 2012 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q4 2015: $1.68 billion | Q1 2016: $2.56 billion | Q2 2016: $2.44 billion | Q3 2016: $2.24 billion | Q1 2017: $2.24 billion | Q2 2017: $2.38 billion | Q3 2017: $2.49 billion | Q1 2018: $2.70 billion | Q2 2018: $2.65 billion | Q3 2018: $2.68 billion | Q1 2019: $2.40 billion | Q2 2019: $2.42 billion | Q3 2019: $2.42 billion | Q1 2020: $2.46 billion | Q2 2020: $2.50 billion | Q3 2020: $2.61 billion | Q1 2021: $2.30 billion | Q2 2021: $2.36 billion | Q3 2021: $2.43 billion | Q1 2022: $2.57 billion | Q2 2022: $2.66 billion | Q3 2022: $2.74 billion | Q1 2023: $2.84 billion | Q2 2023: $2.92 billion | Q3 2023: $2.71 billion | Q1 2024: $2.87 billion | Q2 2024: $2.95 billion | Q3 2024: $3.03 billion | Q1 2025: $3.04 billion | Q2 2025: $3.08 billion | Q3 2025: $3.12 billion.
• Over the full 14 years of available data (2012 to 2025), Acadia Healthcare Company, Inc.'s Stockholders Equity has grown by 350.6%.
• Historical annual values: Fiscal year 2025: $1.95 billion | Fiscal year 2024: $3.07 billion | Fiscal year 2023: $2.78 billion | Fiscal year 2022: $2.81 billion | Fiscal year 2021: $2.52 billion | Fiscal year 2020: $1.90 billion | Fiscal year 2019: $2.51 billion | Fiscal year 2018: $2.33 billion | Fiscal year 2017: $2.57 billion | Fiscal year 2016: $2.17 billion | Fiscal year 2015: $1.68 billion | Fiscal year 2014: $880.97 million | Fiscal year 2013: $480.71 million | Fiscal year 2012: $432.55 million.
• Data sourced from SEC EDGAR public filings as of August 7, 2026.

Last verified: August 7, 2026